Abstract

The mild symptoms in Mild Cognitive Impairment (MCI), a precursor of dementia, often go unnoticed and are assumed as normal aging signs. Such negligence result in late visits which consequently, lead to the diagnosis and progression of dementia. An instrumented gait assessment in home settings may facilitate the detection of subtle MCI-related motor deficits thus, allowing early diagnosis and intervention. This paper investigates potential gait biomarkers derived from shank mounted inertial sensors signals under normal and dual-task walking conditions using data collected from thirty MCI and thirty cognitively normal (CN) subjects. To identify potential gait biomarkers for MCI screening, we assess the variance and predictive power of each feature. Moreover, multiple classification models using different machine learning and feature selection techniques are built to automate MCI detection by leveraging the gait biomarkers. Statistical analysis reveal multiple gait parameters that are significantly different under both single and dual-task settings. However, we show that dual-task walking provides better distinction between MCI and CN subjects. The machine learning model employed for MCI pre-screening based on the inertial sensor-derived gait biomarkers achieves accuracy and sensitivity of 71.67% and 83.33%, respectively.

Highlights

  • T HE prevalence and incidence rate of cognitive problems are evident in the growing elderly population worldwide

  • Alzheimer’s disease (AD) is the most common form that accounts for 60% to 70% of dementia cases and is projected to increase to 115.4 million people worldwide by 2050 [1]

  • The status quo of detecting cognitive impairments typically rely on clinical assessments that are usually contingent on battery of cognitive tests, questionnaires, and physical and neurological examinations

Read more

Summary

Introduction

T HE prevalence and incidence rate of cognitive problems are evident in the growing elderly population worldwide. Mild cognitive impairment (MCI), a slight but noticeable and measurable decline in cognitive abilities, has been established as a precursor to the development of dementia. Nearly 10% to 15% of the elderly people with MCI progress to dementia. MCI screening and early diagnosis is extremely important, preferably under living conditions, in order to diagnose and treat the causative factors and to help prevent or postpone the progression of dementia. This stimulates the research to find novel, inexpensive, and reliable biomarkers for early MCI diagnosis and to facilitate the current clinical diagnosis methods

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.